Skip to main content
. 2023 Mar 30;23:150. doi: 10.1186/s12905-023-02310-6

Fig. 3.

Fig. 3

A Immunostaining with oestrogen (ERx200); B immunostaining with progesterone (PRx200); (C) immunostaining with CK-7 (× 200); (D) immunostaining with P16 (× 200)